|
|
Volumn 97, Issue 14, 2005, Pages 1032-1033
|
|
Risk reduction works for BRCA mutation carriers - With heavy costs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
ESTROGEN;
ORAL CONTRACEPTIVE AGENT;
SEX HORMONE;
BREAST CANCER;
CANCER PREVENTION;
CANCER RISK;
CANCER SCREENING;
CANCER SURVIVAL;
DRUG ABSORPTION;
FEMALE;
GENE MUTATION;
GENETIC PREDISPOSITION;
HETEROZYGOTE;
HIGH RISK POPULATION;
HORMONE SUBSTITUTION;
HUMAN;
LOW DRUG DOSE;
MAMMOGRAPHY;
MASTECTOMY;
MEDICAL DECISION MAKING;
MENOPAUSAL SYNDROME;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVARIECTOMY;
OVARY CANCER;
PREVALENCE;
PRIORITY JOURNAL;
RISK REDUCTION;
SALPINGOOOPHORECTOMY;
ARTICLE;
BREAST TUMOR;
EARLY MENOPAUSE;
GENETICS;
MUTATION;
OVARY TUMOR;
QUALITY OF LIFE;
TUMOR SUPPRESSOR GENE;
BREAST NEOPLASMS;
CONTRACEPTIVES, ORAL, HORMONAL;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
HETEROZYGOTE;
HUMANS;
MASTECTOMY;
MENOPAUSE, PREMATURE;
MUTATION;
OVARIAN NEOPLASMS;
OVARIECTOMY;
QUALITY OF LIFE;
RISK REDUCTION BEHAVIOR;
|
|
EID: 23244439635
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/dji228 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|